Proprietary Name
Proprietary Name - Related Videos
01:25
Solvency Ratios: Proprietary Ratio
0 Views •
2024
The proprietary ratio is a critical financial metric that measures the proportion of a company's assets financed by shareholders' equity. Understanding its importance is crucial for investors, creditors, and the company's management. Lenders prefer companies with a higher proprietary ratio because it suggests financial stability and a lower risk of default. This can result in better borrowing terms and lower interest rates. Investors look for companies with a strong equity base, indicating a...
08:24
Sit-to-stand-and-walk from 120% Knee Height: A Novel Approach to Assess Dynamic Postural Control Independent of Lead-limb
0 Views •
Cited by 5 •
2016
Here, we present a novel protocol to measure positional stability at key events during the sit-to-stand-to-walk using the center-of-pressure to the whole-body-center-of-mass distance. This was derived from the force platform and three-dimensional motion-capture technology. The paradigm is reliable and can be utilized for the assessment of neurologically compromised individuals.
03:25
Imaging of Neuronal Mitochondria Using a Serial Block-Face Scanning Electron Microscope
0 Views •
2025
Source: Mukherjee, K., et. al. Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy. J. Vis. Exp. (2016)This video demonstrates the preparation, imaging, and analysis of mouse brain tissue using a serial block-face scanning electron microscope (SBFSEM) to visualize mitochondrial ultrastructure, enabling precise mapping of their morphology and spatial distribution in axonal and dendritic neuronal compartments.
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
0 Views •
2017
Metabolic competency of in vitro systems is a key requirement for the biotransformation and disposition of drugs and toxicants. In this protocol, we describe the application of reference metabolic probes to assess phase I metabolism in cell cultures.
06:48
Rapid Formation and Testing of Self-expanding NiTi Frames with a Small Form Factor Suitable for Minimally Invasive Implants
0 Views •
Cited by 1 •
2025
This work illustrates a low-cost fabrication technique for shape-setting nitinol wires/frames with a small form factor using sacrificial fixtures. The technique is demonstrated for the fabrication of self-expanding frames designed for minimally invasive implants with complex shapes.
FAQs
The pharmacological effect comes from the product’s chemical composition, formulation, and dose, rather than from its commercial name. These factors determine how the medicine interacts with biological targets and produces its effects. For pharmacology students, separating the name from these active properties prevents a brand label from being mistaken for a mechanism of action.
Different manufacturers or regions may use different commercial names for medicines connected to the same drug or equivalent products. The relevant comparison therefore focuses on the active ingredient, formulation, and dose. This approach helps researchers recognize when differently labeled products should be evaluated through their pharmacological properties rather than through branding alone.
An active ingredient is the chemical component responsible for interaction with biological targets, whereas a Proprietary Name serves to identify the marketed product. This distinction matters when interpreting pharmacology records because the name alone does not specify the mechanism, dose-related behavior, or biological effect. Linking the product label to its active ingredient provides the meaningful scientific context.
Researchers can connect the recorded commercial label with the medicine’s generic or nonproprietary name and then consider its active ingredient, formulation, and dose. This makes prescribing information easier to compare across records, manufacturers, or regions. The process also reduces confusion when the same drug appears under different names and supports clearer pharmacological interpretation.
The comparison should examine the active ingredient, formulation, and dose rather than relying on the similarity or difference between brand labels. Those characteristics relate directly to the product’s pharmacological effects and biological target interactions. In research or prescribing analysis, this comparison helps distinguish a naming difference from a meaningful difference in the medicine being evaluated.
Clinical trial records may identify a medicine by a commercial label, while other sources use its generic or nonproprietary name. Connecting these naming systems allows investigators to recognize the drug consistently across records and compare findings more accurately. It also limits errors caused by regional or manufacturer-specific terminology when interpreting pharmacological evidence.